Evren Alici

4PUBLICATIONS
43CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 15, 2024
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis.

Shi Yong Neo, Le Tong, Joni Chong

|Apr 11, 2023
SHP-1 localization to the activating immune synapse promotes NK cell tolerance in MHC class I deficiency.

Laurent Schmied, Thuy T Luu, Jonas N Søndergaard

|Sep 06, 2022
Conditioning with melphalan 200 mg/m2 and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care.

Gabriel Afram, Roza Chaireti, Katarina Uttervall

|Aug 04, 2020
Outcome of COVID-19 in multiple myeloma patients in relation to treatment.

Katharina Helene Susek, Charlotte Gran, Hans-Gustaf Ljunggren

Pageof 1

Frequent Collaborators

2 joint publications

Hareth Nahi

2 joint publications

Arnika K Wagner

2 joint publications

Lisa S Westerberg

1 joint publications

Katharina Helene Susek